CEA Industries ($BNC) Crosses Half-Million BNB Milestone GlobeNewswire October 21, 2025 Louisville, CO, Oct. 21, 2025 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC) (“BNC” or the “Company”) today announced that it now holds a total of 500,000 BNB tokens, with an average acquisition cost of approximately $870 per BNB, representing a total invested amount […]

EagleNXT Debuts MicaSense RedEdge-P Triple: A Game-Changer for Precision Drone Imaging GlobeNewswire October 21, 2025 Revolutionary triple sensor package delivers superspectral data for agriculture, geospatial, and environmental markets WICHITA, Kan., Oct. 21, 2025 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of advanced drone and

PetVivo Holdings, Inc. Addresses Veterinary Industry's GEN Z Problem With Breakthrough AI License Agreement GlobeNewswire October 21, 2025 MINNEAPOLIS, Oct. 21, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., an emerging biomedical device company focused on the commercialization of groundbreaking medical products

SharpLink Reports Total ETH Holdings Rise to 859,853 as of October 19, 2025; Total ETH and Cash Holdings of $3.5 Billion GlobeNewswire October 21, 2025 Minneapolis, MN, Oct. 21, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world's largest corporate holders of Ether (“ETH”) and prominent industry

Solenic Medical Announces Successful Use of Its AMF Technology Under FDA Compassionate Use Authorization Company to Exhibit at American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2025 GlobeNewswire October 21, 2025 DALLAS, Oct. 21, 2025 (GLOBE NEWSWIRE) — Solenic Medical, a medical device company developing an innovative treatment for orthopedic implant infections, today

AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure GlobeNewswire October 21, 2025 Research Triangle Park, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in participants with New

NIH Grant Awarded to Further Research of Novel Chemical Pathway to Reverse MCI Levels of acetylcholine drop as we age–previously, nothing has been shown to reverse that GlobeNewswire October 21, 2025 SAN FRANCISCO, Oct. 21, 2025 (GLOBE NEWSWIRE) — The NIH has awarded a new grant to Posit Science, the maker of the online BrainHQ

RTI Connext Recognized as the Gold Standard for Accelerating Defense System Deployment This award validates the key role Connext plays in delivering secure, interoperable, and rapidly fielded systems for the U.S. and its allies GlobeNewswire October 21, 2025 SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Real-Time Innovations (RTI), the software framework company for physical

Discover the Extraordinary: Preferred Hotels & Resorts Presents Annual Live Like a Legend Experiences for 2025 The World's Largest Independent Hotel Brand Unveils Six Dream-worthy and Inspiring Luxury Travel Experiences, Offering Unforgettable, Rare Access to the Truly Exceptional GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — Setting a new benchmark for

Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved GlobeNewswire October 21, 2025 Minerva secures $80 million up front and up